Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...
Based on the initial data, Centogene’s chief genomic officer Peter Bauer concluded that the implementation of genetic testing ... Parkinson’s adaptive deep brain stimulation system" was ...
The US Food and Drug Administration (FDA) has approved the first adaptive deep brain stimulation (aDBS) system for Parkinson’s disease (PD) that self-adjusts therapy to individual brain activity ...
Our organizational approach involves three complementary strategies: I) contributing toward theoretical advances in the dynamics of complex adaptive systems, II) rigorous testing of theory through a ...